Haematology Rapid Tests Therapeutics strategies and Product Pipeline Review 2017

Pune, India, 16th August 2017: WiseGuyReports announced addition of new report, titled “Haematology Rapid Tests & Point of Care (POC) – Medical Devices Pipeline Assessment, 2017”.

Summary

Medical Devices sector report, “Haematology Rapid Tests & Point of Care (POC) – Medical Devices Pipeline Assessment, 2017″ provides an overview of Haematology Rapid Tests & Point of Care (POC) currently in pipeline stage.

 

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Haematology Rapid Tests & Point of Care (POC) pipeline products.

 

GET SAMPLE REPORT @https://www.wiseguyreports.com/sample-request/1685778-haematology-rapid-tests-point-of-care-poc-medical-devices-pipeline-assessment-2017       

 

Scope

– Extensive coverage of the Haematology Rapid Tests & Point of Care (POC) under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Haematology Rapid Tests & Point of Care (POC) and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

 

Reasons to buy

The report enables you to –

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Haematology Rapid Tests & Point of Care (POC) under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

 

Table of Content: Key Points

 

1 Table of Contents 2

    1.1 List of Tables 5

    1.2 List of Figures 6

2 Introduction 7

    2.1 Haematology Rapid Tests & Point of Care (POC) Overview 7

3 Products under Development 8

    3.1 Haematology Rapid Tests & Point of Care (POC) – Pipeline Products by Stage of Development 8

    3.2 Haematology Rapid Tests & Point of Care (POC) – Pipeline Products by Segment 9

    3.3 Haematology Rapid Tests & Point of Care (POC) – Pipeline Products by Territory 10

    3.4 Haematology Rapid Tests & Point of Care (POC) – Pipeline Products by Regulatory Path 11

    3.5 Haematology Rapid Tests & Point of Care (POC) – Pipeline Products by Estimated Approval Date 12

4 Haematology Rapid Tests & Point of Care (POC) – Pipeline Products under Development by Companies 13

    4.1 Haematology Rapid Tests & Point of Care (POC) Companies – Pipeline Products by Stage of Development 13

    4.2 Haematology Rapid Tests & Point of Care (POC) – Pipeline Products by Stage of Development 14

5 Haematology Rapid Tests & Point of Care (POC) Companies and Product Overview 16

    5.1 Atomo Diagnostics Pty Limited Company Overview 16

      5.1.1 Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 16

    5.2 BioMedomics Inc Company Overview 17

      5.2.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 17

    5.3 Biosurfit, SA Company Overview 18

      5.3.1 Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview 18

    5.4 Carclo Diagnostic Solutions Ltd Company Overview 20

      5.4.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

    5.5 Cascade Metrix, Inc. Company Overview 21

…Continued        

 

ACCESS REPORT @https://www.wiseguyreports.com/reports/1685778-haematology-rapid-tests-point-of-care-poc-medical-devices-pipeline-assessment-2017      

 

Contact Info:                                                         

NORAH TRENT                                                      

Partner Relations & Marketing Manager

sales@wiseguyreports.com             

Ph: +1-646-845-9349 (US)                

Ph: +44 208 133 9349 (UK)                                                   

 

Get in touch:

LinkedIn: www.linkedin.com/company/4828928

Twitter: https://twitter.com/WiseGuyReports                                                                  

Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts    

Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: www.wiseguyreports.com